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This paper presents the development of water-permeable dialysis membranes that are
suitable for an implantable microdialysis system that does not use dialysis fluid. We
developed a microdialysis system integrating microfluidic channels and nanoporous
filtering membranes made of polyethersulfone (PES), aiming at a fully implantable system
that drastically improves the quality of life of patients. Simplicity of the total system is
crucial for the implantable dialysis system, where the pumps and storage tanks for the
dialysis fluid pose problems. Hence, we focus on hemofiltration, which does not require
the dialysis fluid but water-permeable membranes. We investigated the water permeability
of the PES membrane with respect to the concentrations of the PES, the additives,
and the solvents in the casting solution. Sufficiently, water-permeable membranes were
found through in vitro experiments using whole bovine blood. The filtrate was verified to
have the concentrations of low-molecular-weight molecules, such as sodium, potassium,
urea, and creatinine, while proteins, such as albumin, were successfully blocked by
the membrane. We conducted in vivo experiments using rats, where the system was
connected to the femoral artery and jugular vein. The filtrate was successfully collected
without any leakage of blood inside the system and it did not contain albumin but low-
molecular-weight molecules whose concentrations were identical to those of the blood.
The rat model with renal failure showed 100% increase of creatinine in 5 h, while rats
connected to the system showed only a 7.4% increase, which verified the effectiveness
of the proposed microdialysis system.
Keywords: water permeable, dialysis, membrane, hemofiltration, micro, implantable, artificial kidney, polyether-
sulfone
Introduction
Dialysis therapy is well developed and widely used for patients with end-stage renal diseases, but the
patients must undergo this treatment in hospital for 4 h, three times a week (Kanno andMiki, 2012).
Implantable dialysis systems would reduce the frequency of hospital visits and drastically improve
their quality of life (Yang et al., 2002; Xu and Qusay, 2004; Gu and Miki, 2009). In addition, the
treatment can be conducted for 24 h, 7 days/week, whereas the dialysis therapy runs only for 4 h,
3 days/week. The rather slow and gentle treatment is less harmful to the patients.
The dialysis membrane is one of the critical components that determine dialysis performance.
These membranes allow only low-molecular-weight molecules, such as sodium, potassium, urea,
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and creatinine, to pass through while blocking proteins, such
as albumin, and other larger molecules. Commercialized
dialyzers have membranes made of nanoporous polymers,
which include cellulose, cellulose acetate, polyethersulfone
(PES), polyamide, and poly(methyl methacrylate) (Sakai, 1994).
Micro/nanofabricated silicon membranes have been proposed
and tested as the dialysis membranes of implantable systems
(Fissell and Roy, 2009). The pore sizes, distribution, and even
location can be precisely controlled. Other candidates for the
porous membranes include glass, ceramics, polymers, and
metals, such as platinum black (Tsuru, 2001; Cruz et al., 2005;
Grigoras et al., 2005; Black et al., 2006; Boughaba and Wang,
2006; Shinohara et al., 2006). Our group proposed nanoporous
membranes made of PES (Gu and Miki, 2007). The PES
membranes are formed by the phase inversion method, where the
casting solution can adjust the permeability of the molecules with
respect to the sizes (Gu and Miki, 2007). The PES membranes
were sandwiched by microchannels to form the microdialysis
system, which was experimentally verified to have efficiency
as high as a healthy kidney. Long-term stability of the PES
membranes was investigated in in vitro experiments using whole
cow blood, where nanoporous parylene (Prihandana et al., 2012,
2014a) and fluorinated diamond-like carbon (Prihandana et al.,
2013) were deposited to modify the surface properties of the
membranes.
Another challenge for implantable dialysis systems is miniatur-
ization of the whole system. In our previously proposed system,
microchannels were designed such that blood could be intro-
duced at a sufficiently high-flow rate via blood pressure, i.e.,
no pump was necessary to drive the blood. However, dialysis
fluids need to be stored, introduced, and cleaned, which hin-
ders miniaturization of the system. Therefore, we consider that
hemofiltration is advantageous over hemodialysis since hemofil-
tration does not use dialysis fluid, but removes low-molecular-
weight molecules from blood as an aqueous solution, as shown
in Figure 1 (Jeffrey et al., 1994). While this may lead to a lack
of necessary low-molecular-weight molecules, these can be later
supplied by medication and/or diet.
For hemofiltration, the membranes have to possess sufficient
water permeability while blocking proteins. The PES membrane
used in prior work did not exhibit sufficient water permeability
(Gu and Miki, 2007). In this paper, we investigate the water
permeability of the membrane with respect to the concentrations
of PES, additives, and solvents of the PES casting solution. First,
we conducted in vitro experiments using whole cow blood to find
the best casting solution with respect to the water permeability,
diffusion capacity of low-molecular-weight molecules, blocking
of proteins, and mechanical stability. Then, we characterized the
membrane in in vivo experiments using nephrectomized rats.
Materials and Methods
Materials
Polyethersulfone (molecular weight of 4800, Sumitomo Chemical
Co., Japan) was used as a solute for the membrane. Polyethyleneg-
lycol (PEG,molecularweight of 1000,WakoPureChemical Indus-
tries, Ltd., Japan) and N,N-dimethylacetamide (DMAc, Wako
FIGURE 1 | Concept of no-dialyzate microdialysis system for
implantable artificial kidney.
Pure Chemical Industries, Ltd., Japan) were used as the additive
and solvent in the PES casting solution, respectively. An SUS316L
plate 200µm in thickness was purchased from Nilaco Co., Japan.
SU-8 3050 (MicroChem Co., Japan) was used as a photoresist for
photolithography.
Defibrinated bovine blood used in in vitro experiments was
purchased from Kojin Bio Co., Ltd. Sodium chloride, urea, and
potassium chloride (KCl) were purchased fromWako PureChem-
ical Industries, Ltd., Japan. Saline, heparin, and 32- to 36-week-
old Sprague-Dawley rats were used in in vivo experiments and
were purchased from Otsuka Pharmaceutical Factory Co., Japan,
Mochida Pharmaceutical Co., Ltd., Japan, and Clea Japan, Co.,
Japan, respectively. Isoflurane purchased fromWako Pure Chem-
ical Industries, Ltd., Japan was used as the anesthesia. Ethanol
and 20% glutaraldehyde solution were purchased fromWako Pure
Chemical Industries, Ltd., Japan.
PES Membrane Formation
Polyethersulfone membranes were formed from a casting solu-
tion composed of PES, PEG, and DMAc. The investigated mix-
ing ratios of the solute, additive, and solvent are described in
Table 1. In this experiment, we set the ratio of PES and PEG
constant, which was reported to be a suitable ratio (Chong et al.,
2012). The casting solution was stored at room temperature for
1 day after being mixed to become transparent. Subsequently,
the PES casting solution was poured onto a glass substrate and
spin-coated at 300 rpm to have a thickness of 100µm. The glass
substrate was then immersed into deionized (DI) water for 1 day
at room temperature to remove PEG from the membrane. The
PES membrane was gelatinized and became a white nanoporous
membrane. The pore sizes cannot be directly measured by SEM
since they are too small. However, they are considered to be
on the order of nanometers, which allows low-molecular-weight
molecules to pass through and blocks large molecules, such as
albumin.
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TABLE 1 |Mixing ratio (wt%) of PES/PEG/DMAc and their structures.
PES PEG DMAc
1 10.0 8.3 81.7
2 12.5 10.4 77.1
3 15.0 12.5 72.5
4 17.5 14.5 68.0
5 20.0 16.7 63.3
6 22.5 18.8 58.7
7 25.0 20.8 54.2
FIGURE 2 |Multi-layered microdialysis device consisting of PES
membranes and metal channel layers. The ports are used as the inlet and
outlet for blood and to access the filtrates. The metal channel layers are
formed by electrolytic etching. PES membranes and metal channel layers are
stacked alternately. The channels are connected in parallel, which allows the
total mass flow to be increased without increasing the required pressure.
Fabrication of Microdialysis Devices
The microdialysis system tested in this work comprised multiple
sets of a porous PES membrane and two microfluidic channels
made of SUS316L that sandwich the membrane, as shown in
Figure 2. The system has four ports: the outlet and inlet for the
blood and two access ports for the filtrate. The wide channels are
2mm in width and 72mm in total length. The channel height,
or the thickness of the SUS316L plate, is 200µm. The channels
are designed to have a sufficient volumetric flow rate at a human
blood pressure (Gu andMiki, 2009) (see Figure S1 in Supplemen-
tary Material). SUS316L is a highly biocompatible material. The
microchannels are connected in parallel such that the total volume
of blood can be increased with the number of layers without
increasing the pressure.
The metal layers were formed by electrolytic etching with pho-
tolithographically patterned SU-8 3050 as the masking material.
The electrolyte consists of ethylene glycol, sodium chloride, citric
acid, and DI water. The electrolytic etching was conducted at
an applied voltage of 20V for 5 h. The etching setup is shown
in Figure S2 in Supplementary Material. We overlaid the PES
membranes and the metal layers, and the alignment holes and
screw holes were punched through the PES membranes with a
disposable biopsy punch (Kai Co., Japan). The PES and metal
layers were bonded using the DMAc solvent as the glue.
In vitro Experiments
First, we deduced the most suitable PES membrane for the
no-dialyzate microdialysis system among those formed from
the PES casting solutions listed in Table 1. Whole cow blood
was introduced into the single-layered device, which consisted
of two microchannel layers and a PES membrane, using a
syringe pump at a flow rate of 100ml/min for 100min, when
the pressure of 200mmHg was applied (see Figure S3A in
Supplementary Material for the setup). First, the membrane was
optically inspected to assess the mechanical stability. Fractures
in the membrane allow blood to leak through the membrane.
The filtrate was collected and investigated with respect to the
water permeability, diffusion capacity of low-molecular-weight
molecules, and blocking of proteins.
Water permeability of the membrane was characterized by the
filtration coefficient LP, which is defined as Eq. 1.
LP =
VF
TF  TMP A (1)
where VF is the volume of the permeated water (milliliters), TF
is the filtration time (minutes), TMP is the pressure difference
between the inlet and outlet of the membrane (millimeter of
mercury), andA is the area of themembrane (squaremeter).TMP
was measured using the following Eq. 2.
TMP = ∆P  ∆π (2)
where ∆P is the pressure difference of blood between the inlet
and outlet (millimeter of mercury) and ∆π is the osmotic pressure
caused by protein in blood (millimeter of mercury), which is
defined as Eq. 3.
∆π = CAiRT (3)
where CA is the molar concentration of the protein (mole
per liter), i is a dimensionless number ( ), R is the gas con-
stant [0.0083 lMPa/(molK)], and T is the absolute temperature
(Kelvin). The target value of the filtration coefficient LP to meet
the requirements for hemofiltration treatment of humans was
obtained from a medical doctor; the volume of filtrates needs to
be equivalent to that of urine (~1500ml for adults) at the human
blood pressure.
Next, using the best PES membrane, we investigated how the
number of layers affected the total volume of the filtrate. Scale-up
of the system, in this case by increasing the number of layers, is
crucial for practical applications. We prepared single-layered and
multi-layered devices that had 1, 5, and 10 layers, respectively.
Since the syringe pump could not supply a sufficient amount
of cow blood to the multi-layered device, we used a peristaltic
pump to circulate the cow blood (see Figure S3B in Supplementary
Material for the setup). The inlet pressurewas set to be 130mmHg.
The filtration coefficient LP was deduced for each device.
Concentrations of sodium, potassium, chloride, blood urea
nitrogen (BUN), and albuminweremeasured using a POCTAuto-
mated analyzer for clinical chemistry (SPOTCHEMEZ, ARKRAY
Inc., Japan). These concentrations were compared to those of the
whole cow blood.
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FIGURE 3 | Schematic illustration of the in vivo test. The inlet and outlet
of the device were connected to the femoral artery and jugular vein,
respectively. The blood pressure of the rat was monitored during the
experiments. The volume and components of the filtrate were investigated.
In vivo Experiments
All animals used in the experiments received humane care. The
experimental protocol was approved by the Laboratory Animal
Care and Use Committee following Keio University guidelines.
Female Sprague-Dawley rats (age, 32–36weeks; Clea Japan, Co.,
Japan) were anesthetized with isoflurane and their limbs were
fixed to the surgical table with adhesive tape. The abdominal
cavity was opened and the renal functionwas halted by ligating the
renal artery to stop the blood flow into the kidney. Medical tubes
0.58 and 0.965mm in inner and outer diameters, respectively,
were connected to the femoral artery and jugular vein, which were
sequentially connected to the device inlet and outlet, as shown
in Figure 3. The device and the tubes were filled with heparin
solution (heparin:saline= 1:9) in advance. The blood pressurewas
monitored by a polygraph (RMT 1000, Nihon Koden, Co., Japan)
during the experiments.
We tested 1, 5, and 10 layer devices. Three experiments were
conducted for each device. After 30min, the device was connected
to the rat and the circulating system was formed, we collected the
filtrate every 15min for 80min. After collecting the filtrate, we
injected 5ml of saline to recover the blood pressure. The volume
of the filtrate was measured to evaluate the water permeability
by the filtrate coefficient, and the concentrations of solutes were
measured using the POCT Automated analyzer.
To verify the effectiveness of the hemofiltration treatment with
the device, we investigated the increase of creatinine in the blood
of nephrectomized rats with and without the device. Experiments
were repeated three times. Creatinine is produced by metabolic
reaction, and changes in creatinine levels are widely used to evalu-
ate renal function. The concentration of creatinine increases when
renal function is disrupted. The concentration of creatinine was
measured for 7 h using the POCT Automated analyzer. For the rat
with the device, the first 2 h was used to connect the device to the
rat, and the treatment was conducted for 5 h.
Results and Discussion
Water Permeability of the PES Membrane
The relationship between the PES concentration of the casting
solution and the filtration coefficient LP is shown in Figure 4.
FIGURE 4 | Relationship between PES concentration and the filtration
coefficient. A PES concentration of 17.5% was experimentally found to have
the best filtration coefficient and sufficient mechanical strength.
Three samples were tested, and the error bars represent the mini-
mum and maximum. The target line was drawn based on a value
obtained from a medical doctor to meet the requirements for
hemofiltration treatment of humans. The PES membrane formed
from the casting solution with a PES concentration of 17.5%
had the highest filtration coefficient among all the membranes.
It possessed water permeability higher than the target value
and was also experimentally verified to have sufficient mechan-
ical strength. Thus, this membrane was used in the subsequent
experiments.
There was less PEG additive in membranes with low concen-
trations of PES, and these membranes were considered to have
fewer pores. Therefore, the water permeability increased with the
PES concentration. By contrast, when the PES concentration was
high, the thickness of the nanoporous skin layer of PES, which
determined the permeability, was large, resulting in low water
permeability. This has been reported in previous work (Chong
et al., 2012).
Filtration Capacity of Multi-Layered Devices
We assembled 1, 5, and 10 layer devices using PES membranes
formed from 17.5% PES casting solution, which was found to have
the best water permeability, as described in Section “Water Perme-
ability of the PES Membrane.” Figures 5A,B show the volume of
filtrate from the multi-layered device and the resulting LP. Three
samples were tested, and the error bars represent the minimum
and maximum. Results indicate that the system can be scaled-up
by increasing the number of layers. The slight decrease of LP with
the layer number originates from the pressure drop at the inlet of
the device.
Figures 5C,D show the concentrations of low-molecular-
weightmolecules and albumin of the blood and the filtrate, respec-
tively. Three samples were tested, and the error bars represent
the minimum and maximum. The concentrations of sodium,
potassium, chloride, and BUN of the filtrate are almost iden-
tical to those of the blood. By contrast, albumin, the smallest
protein in the blood plasma, was successfully blocked in all
devices. These filtration properties satisfy the requirements for
hemofiltration.
In vivo Tests
After the device was connected to the rat, the blood pressure
dropped and then fluctuated drastically. This is because a fair
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FIGURE 5 | Filtration capacity of the multi-layered devices. (A) Volume
of filtrate, (B) the filtration coefficient, and the concentrations of
(C) low-molecular-weight molecules: sodium (Na), potassium (K), chlorine (Cl),
and blood urea nitrogen (BUN) and (D) albumin (Alb) in the filtrate. The volume
of filtrate increases with the number of layers, which verifies that the system
can be scaled-up to satisfy the requirements for humans. The filtrate has
almost identical concentrations of solutes as the blood, while it contains no
albumin.
amount of blood was extracted from the body to fill the tubes and
devices, which was compensated by injecting saline. After 1–2 h,
the blood pressure stabilized (see Figure S4 in Supplementary
Material).
FIGURE 6 | (A) Volume of filtrate from multi-layered microfilters and in vivo
tests. (B) The filtration coefficient, and (C) the filtration coefficient of the
devices for 5 h. (D) SEM photo of the tested membrane. The volume of
filtrates in in vivo tests was slightly smaller than that in in vitro tests due to the
lower blood pressure, while the filtration coefficients were comparable. The
coefficient was almost constant with respect to the test periods, although
some biomaterials were found on the PES membrane.
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FIGURE 7 | Concentration of creatinine (Cre) in the nephrectomized
rats with or without our device.
Figure 6A shows the volume of filtrate from our devices in
in vitro and in vivo tests. The volume of filtrate was beyond our
target in both in vitro and in vivo tests. The discrepancy between
the volume of filtrates in in vitro and in vivo tests originates from
the difference in the tension membrane pressure: 130mmHg
in vitro and 50–80mmHg in vivo. As shown in Figure 6B, the
filtration coefficients were comparable. The filtration coefficient
remained almost constant over 5 h of experiments as shown in
Figure 6C. Once experiments were completed, we investigated
themembranes using scanning electronmicroscopy after osmium
coating. As shown in Figure 6D, fibrotic tissues were observed on
the surface. In our previous work, we conducted long-term in vitro
diffusion tests for 28 days using bare PES and surface-treated
PES membranes (Prihandana et al., 2013, 2014a). The diffusion
capacity of the bare PESmembrane deteriorated in the first 7 days;
however, it stabilized for the rest of the test periods. In addition,
we experimentally confirmed that the fibrotic tissues formed
on porous membranes allow low-molecular-weight molecules
to permeate the membranes (Prihandana et al., 2014b). These
results indicate that the dialysis membrane can maintain the
diffusion capacity even with the presence of fibrotic tissues.
Therefore, we consider this formation is acceptable, though
long-term experiments still need to be conducted to verify it.
However, because the long-term experiments performed by
opening the abdomen of rats were challenging, we will conduct
future experiments using larger animals.
We investigated the concentrations of creatinine in the blood
after nephrectomy. Figure 7 shows the creatinine concentration
with and without the filtration device. Three samples were tested,
and the error bars in the figure represent the minimum and
maximum. The creatinine concentration was normalized by that
when the renal function was halted. The operation to connect the
device to the rat took 2 h.During the subsequent 5 h, the creatinine
concentration of the rat without the device increased by ~100%,
while that of the rat connected to the device increased by only
7.4%. The results indicated that the developed filtration device
could suppress the increase of creatinine and, with an appropriate
scale-up of the system, it can replicate renal function sufficiently.
Conclusion
We experimentally deduced the most appropriate PES casting
solution to form a sufficiently water-permeable PES membrane.
The membrane was verified to have a good diffusion capacity
for low-molecular-weightmolecules, while it could block albumin
completely. Scale-up of the system was achieved by testing mul-
tiple layers of the PES membrane sandwiched by microchannel
layers in both in vitro and in vivo experiments with rats. The filtra-
tion system could successfully suppress the increase of creatinine
of a rat by 92.6% after 5 h of treatment. These results verified
that this PES membrane had sufficient water permeability for an
implantable microdialysis system.
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